Drug Type Small molecule drug |
Synonyms Compound 15(Kissei Pharmaceutical) |
Target |
Action antagonists |
Mechanism CGRP receptor antagonists(Calcitonin gene-related peptide type 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H32FN5O3 |
InChIKeyBRTUOYAEDFAFHK-IZZNHLLZSA-N |
CAS Registry2173508-07-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Preclinical | Japan | 03 Jul 2025 | |
Migraine Disorders | Preclinical | Japan | 03 Jul 2025 |